7β-hydroxy-epiandrosterone (7β-OH-EpiA) is an endogenous androgen metabolite that has been shown to exert neuroprotective, anti-inflammatory and anti-estrogenic effects.
Introduction
Epiandrosterone (EpiA; 5α-Androstan-3β-ol-17-one), in the fitness world known as "prohormone", became very popular in the 1990s. It is commonly available on the black market and advertised to be a DHT booster with no estrogenic side effects such as gynecomastia or water retention. However, increased DHT levels after EpiA administration were not demonstrated in a recent experiment (Piper et al. 2017) . 7β-hydroxylated EpiA (7β-OH-EpiA; 5α-Androstane-3β,7β-diol-17-one; Fig. 1 ) is an endogenous androgen metabolite of EpiA and dehydroepiandrosterone (DHEA), respectively, and was reported to even have anti-estrogen effects in vitro (Niro et al. 2012) .
In addition to anti-estrogenic properties, neuroprotective (Pringle et al. 2003) , cytoprotective and immunomodulatory (Davidson et al. 2008, Le Mee et al. S512 Vitku et al. Vol. 67 2008) effects have also been reported. 7β-OH-EpiA reduced ischemia-induced neuronal damage (both in vivo and in vitro) and was suggested as a novel neuroprotective compound. It was concluded that the neuroprotective efficacy lies in the 7-hydroxylation, not in epimerization, because both 7-hydroxy epimers possess neuroprotective properties. However, 7β-OHEpiA was protective at even lower concentrations (10 nM) than the 7α-epimer (100nM) (Pringle et al. 2003) . 7β-OH-EpiA also reduced neurodegeneration in an Alzheimer´s disease model (Dudas et al. 2004) , suggesting that it can have neuroprotective effects in acute as well as chronic diseases. With its antiinflammatory properties and ability to modulate arachidonic acid metabolism, it was also suggested as an alternative approach in the treatment of inflammatory bowel disease .
EpiA can be formed by 2 mechanisms: 1) the classic pathway from androst-4-ene-3,17-dione, or 2) indirectly through a back-door pathway from isopregnanolone (3β-hydroxy-5α-pregnan-20-one) by CYP17A1 (17α-hydroxylase, 17.20 lyase) (Vankova et al. 2016) . 7α-hydroxylation of EpiA is catalyzed by CYP7B1 (oxysterol and steroid 7alpha hydroxylase) (Kim et al. 2004 , Starka 2017 . NADP(H) dependent 11β-hydroxysteroid dehydrogenase type 1 is then responsible for the conversion of 7α-OH-EpiA to 7β-OHEpiA (Hennebert et al. 2007) . Oxygenation of EpiA occurs mainly in the intestine, brain and especially liver (reviewed in El Kihel 2012).
The information about 7β-OH-EpiA and reproductive health is scarce. 7-hydroxylated derivatives of DHEA have been already found in seminal plasma and their possible immunomodulatory and antioxidative properties in this matrix were discussed (Hampl et al. 2003 , Pohanka et al. 2002 . With respect to immunomodulatory effects of 7β-OH-EpiA, its presence in seminal plasma is of interest. To the best of our knowledge no information is available on plasma or seminal plasma levels of 7β-OHEpiA in humans. Therefore, we aimed to develop a sensitive and accurate method to measure 7β-OH-EpiA in both fluids. Furthermore, we determined the relationships between 7β-OH-EpiA and sperm quality assessed by spermiogram values in men with different degrees of fertility.
Methods

Study group
The studied cohort consisted of 191 Czech men (all Caucasian) attending the Pronatal Centre of Assisted Reproduction (Prague, Czech Republic). Our previous study provides a detailed overview of the characteristics of the study population . All subjects underwent an ejaculate examination according to the World Health Organization (WHO) 2010 criteria, and based on these results they were divided into 4 groups: first group consisted of normospermic men, the second group comprised oligospermic, asthenospermic or oligoasthenospermic men, the third group included teratospermic, oligoasthenoteratospermic and asthenoteratospermic men, while the fourth group consisted of azoospermic men. We termed these groups: 1) healthy men, and 2) slightly, 3) moderately and 4) severely infertile men. Table 1 shows the basic characteristics of these groups.
The mean age (± SD) of all participants was 35.8±5.6 years and mean BMI value was 27.2±3.6 kg/m 2 . 55 % of men in our study were overweight and 20 % were obese (BMI>30). Neither BMI values, nor age, nor abstinence time significantly differed among the groups of men studied (Table 1, Vitku et al. 2016) .
The study was performed in accordance with the Declaration of Helsinki (2000) of the World Medical Association. The protocol was approved by the Ethical Committee of the Institute of Endocrinology. Informed and written consent with the use of biological materials were obtained from all subjects before participating in the project.
Chemicals and reagents
The steroids 7β-OH-EpiA and D2-7β-OH-EpiA were synthesized in Laboratoire de Chimie moléculaire, Conservatoire National des Arts et Métiers as previously described (Ferroud et al. 2012 , Ricco et al. 2011 . 2-hydrazinopyridine, ammonium formate and trifluoroacetic acid were from Sigma-Aldrich (St. Louis, Data are shown as means and 95.0 % confidence intervals (in the parentheses) for each group, the levels of significance of the model and multiple comparisons are provided. Group 1 -normospermic men, Group 2 -oligospermic/asthenospermic/oligoasthenospermic men, Group 3 -teratospermic/oligoteratospermic/oligoasthenoteratospermic men, Group 4 -azoospermic men. Vol. 67 Table 3 . LC conditions and parameters of validation for plasma and seminal 7β-OH-EpiA. 
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Standard additions were 0.06, 0.3 and 0.72 ng/ml in plasma and 0.12 and 0.6 ng/ml in seminal plasma. Precision is presented as ranges from all additions (during single analytical run for intra-day precision and during three runs in different days for inter-day precision, respectively). LLOQ -lower limit of quantification. Table 4 . Comparison of plasma and seminal levels of 7β-OH-EpiA in ng/ml in groups of men with different degrees of infertility.
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Data are shown as means and 95.0 % confidence intervals (in parentheses) for each group; the levels of significance of the model and multiple comparisons are provided. p-value<0.05 is highlighted in bold. Group 1 -normospermic men, Group 2 -oligospermic/asthenospermic/oligoasthenospermic men, Group 3 -teratospermic/oligoteratospermic/oligoasthenoteratospermic men, Group 4 -azoospermic men. 
Sample preparation
Determination of 7β-OH-EpiA in plasma and seminal plasma was added to an existing method that has already been published . In brief, a sample of plasma (500 µl) or seminal plasma (1,000 µl) was spiked with 10 µl of an internal standard (IS) mixture (deuterated analogues of 7β-OH-EpiA, pregnenolone, 17-OH-pregnenolone, dehydroepiandrosterone -DHEA, 7α-OH-DHEA, 7-oxo-DHEA, cortisol, cortisone, testosterone, androstendione, dihydrotestosterone) and diluted with 500 µl of physiological solution. Samples were shaken, and a liquid-liquid extraction using diethyl ether (3 ml, 1 min) was performed. Dry residues were derivatized by 100 µl of 2-hydrazinopyridine (Fig. 2) in methanol with the addition of trifluoroacetic acid (1 mg: 5 ml: 1.63 µl) according to Higashi et al. (2007) . The samples were again shortly shaken and then sonicated for 15 min. After evaporating under a gentle stream of nitrogen, samples were redissolved in 100 µl of 5 mM ammonium formate in 60 % methanol, of which 50 µl was injected into the liquid chromatograph.
Liquid chromatography/mass spectrometry (LC-MS/MS) of steroids
An ultra-high pressure liquid chromatography (UHPLC) Eksigent ultraLC 110 system (Redwood City, CA, USA) equipped with a Kinetex C18 column (100 x 3.0 mm, 2.6 µm; Phenomenex, Torrance, CA, USA) and Security Guard ULTRA cartridge system (UHPLC C18 for 3 mm ID column; Phenomenex, Torrance, CA, USA) was used for analyte separation. Column temperature was maintained at 50 °C and separation was carried out at a flow rate of 0.75 ml/min. Detection of the analytes was performed on an API 3200 mass spectrometer (Sciex, Concord, Canada) with an electrospray ionization (ESI) probe operating in positive mode. Retention times and transitions with optimized conditions for MS for 7β-OH-EpiA and D2-7β-OH-EpiA are summarized in Table 2 . Example of the chromatogram obtained from the real sample (concentration of 7β-OH-EpiA 2.64 ng/ml) is provided in Figure 3 . Analyst 1.6 software was used for system control and data evaluation. More information about the LC-MS/MS conditions can be found in the study of Sosvorova et al. (2015) . Calibration ranges, correlation coefficients of calibration curves and lower limits of quantifications (LLOQs) are provided in Table 3 .
Validation
Validation parameters met the criteria of the FDA Guidance for Industry (Food nad Drug Administration 2001) in terms of selectivity, accuracy, precision, recovery, calibration curve, and stability of analyte in spiked samples. Acceptable selectivity was defined as the absence of any detectable SRM LC-MS/MS ion currents at the retention time regions of each analyte and its deuterated standards in charcoal treated plasma samples. Samples were tested for further interference during prevalidation phase. Validation experiments included standard additions of 7β-OH-EpiA Vol. 67 in six replicates. Four different concentrations were measured in the plasma matrix (pooled plasma + 3 additions), whereas only 3 different concentrations where measured in seminal plasma (pooled seminal plasma + 2 additions) due to the limited amount of seminal plasma matrix. Accuracy, precision and recovery were then determined and are shown in Table 3 . The spiked concentrations were 0.06, 0.3 and 0.72 ng/ml in plasma and 0.12 and 0.6 ng/ml in seminal plasma. Stability tests and matrix effects were evaluated as well, with satisfactory results. More details on performing validation tests can be found in Vitku et al. (2016) . 
Statistical analysis
Data that were below the limit of detection were replaced by LOD/√2 (Hornung and Reed 1990). All data were subsequently transformed by Box-Cox transformation due to non-Gaussian distribution and heteroscedasticity of variables. One-way analysis of variance (ANOVA) followed by least square difference multiple comparisons was used to evaluate differences between groups of variously infertile men. Partial correlations adjusted for age, BMI and abstinence time were used for assessing relationships between levels of 7β-OH-EpiA and parameters of sperm quality. The statistical software Statgraphics Centurion XVI from Statpoint Inc. (Warrenton, VA, USA) was used for data transformations, ANOVA testing and multiple comparisons. Partial correlations analyses were performed using NCSS 2007 (Kaysville, UT, USA).
Results
We analyzed 191 samples of plasma and seminal plasma. 7β-OH-EpiA was detected in 65 % of plasma samples and 84 % of seminal samples. Differences between plasma and seminal levels of 7β-OH-EpiA in 4 groups of men with various degree of infertility are given in Table 4 . Seminal plasma showed a mild accumulation of this steroid in comparison with blood plasma. Furthermore, 7β-OH-EpiA concentrations in seminal plasma increase from healthy men towards severely infertile men. The same trend was also observed for 7β-OH-EpiA levels in plasma.
Partial correlations adjusted for age, BMI and abstinence time between sperm parameters and 7β-OH-EpiA in both body fluids are given in Table 5 . Plasma 7β-OH-EpiA negatively correlated with sperm concentration and total count, while 7β-OH-EpiA in seminal plasma was negatively associated with motility including progressively motile spermatozoa and nonprogressively motile spermatozoa. Taken together, these observations indicated negative associations of this steroid with sperm quality.
To be complete, we investigated the relationships between plasma and seminal 7β-OH-EpiA and the following other steroids measured in our previous study in the same cohortpregnenolone, 17-hydroxy-pregnenolone, cortisol, cortisone, DHEA, 7α-hydroxy-DHEA, 7β-hydroxy-DHEA, 7-oxo-DHEA, testosterone, androstenedione, dihydrotestosterone, 17β-estradiol, estrone and estriol. No correlations except for a positive correlation of 7β-OH-EpiA with DHEA in seminal plasma (r=0.227; p=0.009) were found. The correlation coefficient of partial correlation r is a measure of the strength between variables and the p-value shows statistical significance. p-value<0.05 are highlighted in bold.
Discussion
To the best of our knowledge, this is the first study to determine 7β-OH-EpiA concentrations in human body fluids. Derivatization by 2-hydrazinopyridine in the method enhanced the sensitivity and enabled us to analyze this androgen metabolite in the pg/ml order of magnitude, which are the concentrations occurring in plasma and seminal plasma. 2-hydrazinopyridine has also been previously used for derivatization of oxosteroids with satisfactory results (Higashi et al. 2007 , Lionetto et al. 2017 .
The concentrations of 7β-OH-EpiA were found to range from LLOQ-0.167 ng/ml (0.549 nmol/l) in normospermic male plasma and LLOQ-0.358 ng/ml (1.176 nmol/l) in seminal plasma. In comparison with other 7-hydroxylated C19 steroids, the plasma concentrations were within the same order of magnitude or slightly lower (Hampl et al. 2003 , Macova et al. 2014 , Starka et al. 2006 , Vitku et al. 2017 . Concentrations of 7β-OH-DHEA have been found to be lower in seminal plasma than in plasma , in contrast to 7β-OH-EpiA where an accumulation in seminal plasma was observed.
The most striking differences were found between seminal concentrations of 7β-OH-EpiA in healthy men and severely infertile men; however, the whole steroid hormonal balance seems to be disrupted in men with impaired spermatogenesis. Seminal T (Zalata et al. 2014 , Zhang et al. 2010 , DHT (Vitku et al. 2016 , Zalata et al. 1995 and androstenedione (Zalata et al. 2014 ) levels have been found to decrease towards infertile men. On the other hand, seminal concentrations of 17α-hydroxy-progesterone (Zalata et al. 2014 ), progesterone (Zalata et al. 2014 , DHEA (Vitku et al. 2016 ), 5α-androstane-3α,17β-diol (Zalata et al. 2014 ), E2 (Bujan et al. 1993 , Luboshitzky et al. 2002 , Zalata et al. 2014 , Zhang et al. 2010 , other estrogens , as well as 7β-OH-EpiA have been found to increase.
These are preliminary data and the molecular mechanism of 7β-OH-EpiA action in semen is unknown so far. We could hypothesize that the steroidogenic pathway towards DHT is supressed on behalf of the production of E2 and 7β-OH-EpiA. The elevated levels of the cytoprotective 7β-OH-EpiA in infertile men could be a compensatory mechanism towards an improvement of sperm quality.
Conclusion
Many steroids circulate in the human body, some of which have biological activity, while others are precursors or metabolites (without biological activity). The functions of many of these other steroids including 7β-OH-EpiA are frequently insufficiently explored. Here we contribute information on the concentration ranges of this steroid in healthy men compared to men with different degrees of fertility. The data revealed a negative relationship between 7β-OH-EpiA and sperm parameters, and may help to better understand changes in the steroid pathway in relation to partial or complete infertility.
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